The Institute for Clinical and Economic Review (ICER) is an independent, non-profit research institute that conducts evidence-based reviews of healthcare interventions, including prescription drugs, treatments, and diagnostic tests. Established in 2006, ICER provides objective evaluations to inform decision-making in the U.S. healthcare system.
icer.org
Core Functions of ICER
ICER’s primary responsibilities include:- Evidence-Based Assessments: Conducting comprehensive reviews to evaluate the clinical effectiveness and value of medical interventions. icer.org
- Value Framework Development: Establishing frameworks to guide the assessment of healthcare interventions’ value, promoting fair pricing and access. icer.org
- Policy Recommendations: Providing guidance to stakeholders, including policymakers and payers, to support informed healthcare decisions.
Leadership and Key Contacts
As of January 2025, ICER is led by President Sarah K. Emond, MPP, who oversees the organization’s strategic initiatives and operations.Contact Details for ICER
Website: https://icer.org/ Postal Address: Institute for Clinical and Economic Review Two Liberty Square, Ninth Floor Boston, MA 02109 United States Telephone: +1 617-528-4013Challenges in Working with ICER
Engaging with ICER involves:- Understanding Assessment Methodologies: Familiarity with ICER’s evaluation processes and value frameworks is crucial for successful market access.
- Timely and Accurate Submissions: Ensuring that all necessary documentation is complete and submitted promptly to facilitate evaluation processes.
- Demonstrating Value for Money: Providing robust evidence that new treatments offer value for money within the U.S. healthcare framework.
Opportunities / Solutions with Justin Stindt Consultants
Justin Stindt’s ICER expertise ensures:- Expert Consultant ICER Submissions: Creating high-quality submissions for healthcare intervention assessments.
- Market Access ICER Strategies: Developing strategies that align with ICER’s evaluation framework to optimize market access.
- Specialist ICER Processes: Providing insights into ICER’s procedures to enhance compliance and expedite approvals.
Case Studies
A Pharmaceutical Company’s Success with ICER
Challenge:
A pharmaceutical company sought our assistance to obtain a favorable assessment and reimbursement for a novel therapy in the U.S.
Solution:
We guided them in preparing a comprehensive dossier that addressed ICER’s evaluation criteria.
Outcome:
Our strategic approach led to a positive outcome, facilitating the therapy’s acceptance in the U.S. healthcare market.
Need support with ICER market access? Justin Stindt Consultants has the expertise to help you succeed.
Contact us today to discuss your market access strategy and ensure your success with ICER.
Other Key Institutions in Market Access
Global Institutions
- World Health Organization (WHO)
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
United States
- Centers for Medicare & Medicaid Services (CMS)
- Academy of Managed Care Pharmacy (AMCP)
- Institute for Clinical and Economic Review (ICER)
France
Germany
- Gemeinsamer Bundesausschuss (G-BA)
- Institute for Quality and Efficiency in Health Care (IQWiG)
- GKV Spitzenverband
United-Kingdom
- National Institute for Health and Care Excellence (NICE)
- Scottish Medicines Consortium (SMC)
- All Wales Medicines Strategy Group (AWMSG)
- National Health Service (NHS)
Italy
Spain
- Spanish Agency of Medicines and Medical Devices (AEMPS)
- Dirección General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia (DGCF)
- Interministerial Commission on Medicine Prices (CIPM)
